{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:02:08Z","timestamp":1791388928194,"version":"4.3.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation\uff1a GLP-1RA induces TAZ gene modification of BMSCs to treat for diabetic osteoporosis","award":["NO. 82170892"],"award-info":[{"award-number":["NO. 82170892"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24633-0","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:15:05Z","timestamp":1763554505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["GLP-1RA in JBMMSCs promoted osteogenic differentiation via modulating CREB and BRD4 signaling mediated proliferation and stemness"],"prefix":"10.1038","volume":"15","author":[{"given":"Huiming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"24633_CR1","doi-asserted-by":"publisher","first-page":"1539411","DOI":"10.3389\/fphar.2025.1539411","volume":"16","author":"Y TIAN","year":"2025","unstructured":"TIAN, Y. et al. Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt\/LRP5\/\u03b2-catenin signaling pathway [J]. Front. Pharmacol. 16, 1539411 (2025).","journal-title":"Front. Pharmacol."},{"issue":"10169","key":"24633_CR2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"COMPSTON J E","year":"2019","unstructured":"COMPSTON J E & MCCLUNG M R LESLIE W D. Osteoporosis [J]. Lancet 393 (10169), 364\u2013376 (2019).","journal-title":"Lancet"},{"issue":"6","key":"24633_CR3","doi-asserted-by":"publisher","first-page":"104823","DOI":"10.1016\/j.jbc.2023.104823","volume":"299","author":"W YUAN","year":"2023","unstructured":"YUAN, W. et al. Reduced APPL1 impairs osteogenic differentiation of mesenchymal stem cells by facilitating MGP expression to disrupt the BMP2 pathway in osteoporosis [J]. J. Biol. Chem. 299 (6), 104823 (2023).","journal-title":"J. Biol. Chem."},{"key":"24633_CR4","doi-asserted-by":"crossref","unstructured":"Ionita-radu, F. et al. Correlation between trabecular bone score and homocysteine level in rheumatoid arthritis patients on Anti-TNF inhibitors [J]. Life (Basel), 14(4). 463 (2024).","DOI":"10.3390\/life14040463"},{"issue":"3","key":"24633_CR5","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s00210-024-03378-z","volume":"398","author":"R ABO-ELENIN M H H, KAMEL","year":"2025","unstructured":"ABO-ELENIN M H H, KAMEL, R. et al. The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis [J]. Naunyn Schmiedebergs Arch. Pharmacol. 398 (3), 2677\u20132693 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"10","key":"24633_CR6","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s00198-022-06454-3","volume":"33","author":"PL XIAO","year":"2022","unstructured":"XIAO, P. L. et al. Global, regional prevalence, and risk factors of osteoporosis according to the world health organization diagnostic criteria: a systematic review and meta-analysis [J]. Osteoporos. Int. 33 (10), 2137\u20132153 (2022).","journal-title":"Osteoporos. Int."},{"key":"24633_CR7","doi-asserted-by":"publisher","first-page":"1199751","DOI":"10.3389\/fimmu.2023.1199751","volume":"14","author":"X LI","year":"2023","unstructured":"LI, X. et al. Glycolytic reprogramming in macrophages and MSCs during inflammation [J]. Front. Immunol. 14, 1199751 (2023).","journal-title":"Front. Immunol."},{"key":"24633_CR8","doi-asserted-by":"crossref","unstructured":"MA, S. et al. BMSC-Derived Exosomal CircHIPK3 promotes osteogenic differentiation of MC3T3-E1 cells via mitophagy [J]. Int. J. Mol. Sci., 24(3). 2785 (2023).","DOI":"10.3390\/ijms24032785"},{"key":"24633_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2021.05.014","volume":"123","author":"V Fischer","year":"2022","unstructured":"Fischer, V. & Haffner-luntzer, M. Interaction between bone and immune cells: implications for postmenopausal osteoporosis [J]. Semin. Cell Dev. Biol. 123, 14\u201321 (2022).","journal-title":"Semin. Cell Dev. Biol."},{"issue":"2","key":"24633_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00223-024-01240-1","volume":"115","author":"L AL REFAIE A, BALDASSINI","year":"2024","unstructured":"AL REFAIE A, BALDASSINI, L. et al. Glucagon-like Peptide-1 receptor agonists and diabetic osteopathy: another positive effect of incretines? A 12 months longitudinal study [J]. Calcif Tissue Int. 115 (2), 160\u2013168 (2024).","journal-title":"Calcif Tissue Int."},{"issue":"3","key":"24633_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tcm.2021.12.008","volume":"33","author":"JS CHAO A M, TRONIERI","year":"2023","unstructured":"CHAO A M, TRONIERI, J. S. et al. Semaglutide for the treatment of obesity [J]. Trends Cardiovasc. Med. 33 (3), 159\u2013166 (2023).","journal-title":"Trends Cardiovasc. Med."},{"key":"24633_CR12","doi-asserted-by":"crossref","unstructured":"CHUONG, V. & FAROKHNIA, M. KHOM S, et al. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission [J]. JCI Insight, 8(12). e170671 (2023).","DOI":"10.1172\/jci.insight.170671"},{"issue":"1","key":"24633_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12933-023-01829-0","volume":"22","author":"M SCHECHTER","year":"2023","unstructured":"SCHECHTER, M. et al. Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence [J]. Cardiovasc. Diabetol. 22 (1), 126 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"24633_CR14","doi-asserted-by":"publisher","first-page":"101351","DOI":"10.1016\/j.molmet.2021.101351","volume":"57","author":"DRUCKER D J","year":"2022","unstructured":"DRUCKER D J GLP-1 physiology informs the pharmacotherapy of obesity [J]. Mol. Metabolism. 57, 101351 (2022).","journal-title":"Mol. Metabolism"},{"key":"24633_CR15","doi-asserted-by":"crossref","unstructured":"KITAURA, H. et al. Effects of Incretin-Related diabetes drugs on bone formation and bone resorption [J]. Int. J. Mol. Sci., 22(12). 6578 (2021).","DOI":"10.3390\/ijms22126578"},{"issue":"4","key":"24633_CR16","doi-asserted-by":"publisher","first-page":"e15188","DOI":"10.1016\/j.heliyon.2023.e15188","volume":"9","author":"Y ZHENG","year":"2023","unstructured":"ZHENG, Y. et al. P53 negatively regulates the osteogenic differentiation in jaw bone marrow MSCs derived from diabetic osteoporosis [J]. Heliyon 9 (4), e15188 (2023).","journal-title":"Heliyon"},{"issue":"1","key":"24633_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12951-023-01871-w","volume":"21","author":"Z YANG","year":"2023","unstructured":"YANG, Z. et al. Hydrogel armed with Bmp2 mRNA-enriched exosomes enhances bone regeneration [J]. J. Nanobiotechnol. 21 (1), 119 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"24633_CR18","doi-asserted-by":"crossref","unstructured":"XIAO, Y. et al. Advances in the Roles of ATF4 in Osteoporosis [J] Vol. 169, 115864 (Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie, 2023).","DOI":"10.1016\/j.biopha.2023.115864"},{"key":"24633_CR19","doi-asserted-by":"crossref","unstructured":"HWANG Y J, HWANG H J, GO, H. et al. Sword bean (Canavalia gladiata) pods induce differentiation in MC3T3-E1 osteoblast cells by activating the BMP2\/SMAD\/RUNX2 pathway [J]. Nutrients, 15(20). 4372 (2023).","DOI":"10.3390\/nu15204372"},{"key":"24633_CR20","doi-asserted-by":"publisher","first-page":"937956","DOI":"10.3389\/fendo.2022.937956","volume":"13","author":"L GAMBARI","year":"2022","unstructured":"GAMBARI, L., GRIGOLO, B. & GRASSI, F. Dietary organosulfur compounds: emerging players in the regulation of bone homeostasis by plant-derived molecules [J]. Front. Endocrinol. (Lausanne). 13, 937956 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"24633_CR21","doi-asserted-by":"publisher","first-page":"1012508","DOI":"10.3389\/fendo.2022.1012508","volume":"13","author":"BAI R J","year":"2022","unstructured":"BAI R J, LI Y S & ZHANG F J Osteopontin, a Bridge links osteoarthritis and osteoporosis [J]. Front. Endocrinol. 13, 1012508 (2022).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"24633_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jds.2023.04.016","volume":"19","author":"B LOPEZ-ANDALUZ J, FLORES-FRAILE J, J","year":"2024","unstructured":"LOPEZ-ANDALUZ J, FLORES-FRAILE J, JAVIER, B. et al. Assessment of rhBMP-2-loaded bovine hydroxyapatite granules in the guided bone regeneration of critical bone defect in rat mandible bone [J]. J. Dent. Sci. 19 (1), 276\u2013284 (2024).","journal-title":"J. Dent. Sci."},{"issue":"1","key":"24633_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/prd.12422","volume":"89","author":"YUB WANG","year":"2022","unstructured":"WANG, Y. U. B. Osteoporosis and periodontal diseases - An update on their association and mechanistic links [J]. Periodontology 2000. 89 (1), 99\u2013113 (2022).","journal-title":"Periodontology 2000"},{"key":"24633_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jot.2022.02.001","volume":"32","author":"C MEUROT","year":"2022","unstructured":"MEUROT, C. & JACQUES, C. Targeting the GLP-1\/GLP-1R axis to treat osteoarthritis: A new opportunity? [J]. J. Orthop. Translat. 32, 121\u2013129 (2022).","journal-title":"J. Orthop. Translat"},{"issue":"3","key":"24633_CR25","first-page":"234","volume":"41","author":"X WU","year":"2018","unstructured":"WU, X. et al. Liraglutide inhibits the apoptosis of MC3T3-E1 cells induced by serum deprivation through cAMP\/PKA\/beta-Catenin and PI3K\/AKT\/GSK3beta signaling pathways [J]. Mol. Cells. 41 (3), 234\u2013243 (2018).","journal-title":"Mol. Cells"},{"key":"24633_CR26","doi-asserted-by":"publisher","first-page":"110523","DOI":"10.1016\/j.biopha.2020.110523","volume":"130","author":"Z LI","year":"2020","unstructured":"LI, Z. et al. Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the Inhibition of NF-kappaB and MAPK pathways via GLP-1R [J]. Biomed. Pharmacother. 130, 110523 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"24633_CR27","doi-asserted-by":"crossref","unstructured":"JEON Y K et al. Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells [J]. Endocrinology and metabolism (Seoul, Korea), 29(4): 567\u201373. (2014).","DOI":"10.3803\/EnM.2014.29.4.567"},{"issue":"1","key":"24633_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s10020-022-00574-6","volume":"28","author":"Q XU","year":"2022","unstructured":"XU, Q. et al. Exenatide regulates Th17\/Treg balance via PI3K\/Akt\/FoxO1 pathway in db\/db mice [J]. Mol. Med. 28 (1), 144 (2022).","journal-title":"Mol. Med."},{"key":"24633_CR29","doi-asserted-by":"crossref","unstructured":"ZHANG, Y. et al. Novel angiogenesis role of GLP-1(32\u201336) to rescue diabetic ischemic lower limbs via GLP-1R-Dependent Glycolysis in mice [J]. Arterioscler Thromb Vasc Biol, 44(6): 1225\u20131245. (2024).","DOI":"10.1161\/ATVBAHA.124.320714"},{"key":"24633_CR30","doi-asserted-by":"crossref","unstructured":"MOON S H, CHUNG Y C, H. Y. U. N. C. G. Tobramycin promotes melanogenesis by upregulating p38 MAPK protein phosphorylation in B16F10 melanoma cells [J]. Antibiot. (Basel), 8(3). 140 (2019).","DOI":"10.3390\/antibiotics8030140"},{"issue":"1","key":"24633_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12964-022-00852-0","volume":"20","author":"S YIN","year":"2022","unstructured":"YIN, S. et al. Receptor activity-modifying protein 1 regulates mouse skin fibroblast proliferation via the G\u03b1i3-PKA-CREB-YAP axis [J]. Cell. Communication Signaling: CCS. 20 (1), 52 (2022).","journal-title":"Cell. Communication Signaling: CCS"},{"key":"24633_CR32","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.omtn.2021.01.008","volume":"23","author":"S YANG","year":"2021","unstructured":"YANG, S. et al. Epigenetically modulated miR-1224 suppresses the proliferation of HCC through CREB-mediated activation of YAP signaling pathway [J]. Mol. Therapy Nucleic Acids. 23, 944\u2013958 (2021).","journal-title":"Mol. Therapy Nucleic Acids"},{"issue":"44","key":"24633_CR33","doi-asserted-by":"publisher","first-page":"17008","DOI":"10.1074\/jbc.RA118.004706","volume":"293","author":"Y SHIOZAKI","year":"2018","unstructured":"SHIOZAKI, Y. et al. The CDK9-cyclin T1 complex mediates saturated fatty acid-induced vascular calcification by inducing expression of the transcription factor CHOP [J]. J. Biol. Chem. 293 (44), 17008\u201317020 (2018).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"24633_CR34","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1038\/s41467-021-24687-4","volume":"12","author":"W WANG","year":"2021","unstructured":"WANG, W. et al. Stromal induction of BRD4 phosphorylation results in chromatin remodeling and BET inhibitor resistance in colorectal cancer [J]. Nat. Commun. 12 (1), 4441 (2021).","journal-title":"Nat. Commun."},{"issue":"9","key":"24633_CR35","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/leu.2016.393","volume":"31","author":"W SAENZ D T, FISKUS","year":"2017","unstructured":"SAENZ D T, FISKUS, W. et al. Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells [J]. Leukemia 31 (9), 1951\u20131961 (2017).","journal-title":"Leukemia"},{"issue":"19","key":"24633_CR36","doi-asserted-by":"publisher","first-page":"e38188","DOI":"10.1016\/j.heliyon.2024.e38188","volume":"10","author":"R BAI","year":"2024","unstructured":"BAI, R. et al. The mechanism of TGF-\u03b2 mediating BRD4\/STAT3 signaling pathway to promote fibroblast proliferation and thus promote keloid progression [J]. Heliyon 10 (19), e38188 (2024).","journal-title":"Heliyon"},{"key":"24633_CR37","doi-asserted-by":"crossref","unstructured":"WANG, X., XU, J. & KANG, Q. Neuromodulation of bone: role of different peptides and their interactions (Review) [J]. Mol. Med. Rep., 23(1). 32 (2021).","DOI":"10.3892\/mmr.2020.11670"},{"issue":"6","key":"24633_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/15384047.2016.1178883","volume":"17","author":"F KYRITSI","year":"2016","unstructured":"KYRITSI, F. & PRICE D K FIGG W D. YAP controls transcriptional elongation through CKD9 recruitment for proximal pause release: Hippo-thetical, new therapeutic targets? [J]. Cancer Biol. Ther. 17 (6), 592\u2013594 (2016).","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"24633_CR39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.adaj.2023.08.007","volume":"154","author":"A MANTESSO","year":"2023","unstructured":"MANTESSO, A. & NOR, J. E. Stem cells in clinical dentistry [J]. J. Am. Dent. Assoc. 154 (12), 1048\u20131057 (2023).","journal-title":"J. Am. Dent. Assoc."},{"key":"24633_CR40","doi-asserted-by":"crossref","unstructured":"OFITERU A M, BECHERU D F, GHARBIA, S. et al. Qualifying osteogenic potency assay metrics for human multipotent stromal cells: TGF-\u03b22 a telling eligible biomarker [J]. Cells, 9(12). 2559 (2020).","DOI":"10.3390\/cells9122559"},{"issue":"1","key":"24633_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13018-023-03767-9","volume":"18","author":"X RU","year":"2023","unstructured":"RU, X. et al. Temporal transcriptome highlights the involvement of cytokine\/JAK\/STAT3 signaling pathway in the osteoinduction of BMSCs [J]. J. Orthop. Surg, Res. 18 (1), 289 (2023).","journal-title":"J. Orthop. Surg, Res."},{"issue":"10","key":"24633_CR42","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/s41388-019-1134-6","volume":"39","author":"A HERRMANN","year":"2020","unstructured":"HERRMANN, A. et al. Integrin alpha6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells [J]. Oncogene 39 (10), 2156\u20132169 (2020).","journal-title":"Oncogene"},{"issue":"712","key":"24633_CR43","doi-asserted-by":"publisher","first-page":"eabj8393","DOI":"10.1126\/scisignal.abj8393","volume":"14","author":"Y SHEN","year":"2021","unstructured":"SHEN, Y. et al. STAT3-YAP\/TAZ signaling in endothelial cells promotes tumor angiogenesis [J]. Sci. Signal. 14 (712), eabj8393 (2021).","journal-title":"Sci. Signal."},{"issue":"1","key":"24633_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13058-024-01800-1","volume":"26","author":"J LI","year":"2024","unstructured":"LI, J. et al. UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5 [J]. Breast Cancer Res. 26 (1), 44 (2024).","journal-title":"Breast Cancer Res."},{"issue":"3","key":"24633_CR45","doi-asserted-by":"publisher","first-page":"110244","DOI":"10.1016\/j.celrep.2021.110244","volume":"38","author":"CATAL\u00e0-MOLL","year":"2022","unstructured":"CATAL\u00e0-MOLL et al. Vitamin D receptor, STAT3, and TET2 cooperate to Establish tolerogenesis [J]. Cell. Rep. 38 (3), 110244 (2022).","journal-title":"Cell. Rep."},{"issue":"5","key":"24633_CR46","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.3802\/jgo.2024.35.e64","volume":"35","author":"F XUE","year":"2024","unstructured":"XUE, F. et al. TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR\/ERK pathway [J]. J. Gynecol. Oncol. 35 (5), e64 (2024).","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"24633_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jhep.2018.02.014","volume":"69","author":"JJ LIU","year":"2018","unstructured":"LIU, J. J. et al. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic beta-Catenin, PIK3CA and MET [J]. J. Hepatol. 69 (1), 79\u201388 (2018).","journal-title":"J. Hepatol."},{"issue":"3","key":"24633_CR48","doi-asserted-by":"publisher","first-page":"e4914","DOI":"10.1371\/journal.pone.0004914","volume":"4","author":"D WU","year":"2009","unstructured":"WU, D. et al. A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase [J]. PLoS One. 4 (3), e4914 (2009).","journal-title":"PLoS One"},{"issue":"11","key":"24633_CR49","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1002\/jcp.24075","volume":"227","author":"MM FEI Y, HURLEY","year":"2012","unstructured":"FEI Y, HURLEY, M. M. Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation [J]. J. Cell. Physiol. 227 (11), 3539\u20133545 (2012).","journal-title":"J. Cell. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24633-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:15:14Z","timestamp":1763554514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24633-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24633"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24633-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Animal Welfare and Ethics Committee of Hebei Medical University (IACUC-Hebmu-2025047).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical"}}],"article-number":"40773"}}